[1]
S. Kareemulla, B. Himabindu, D. S. Khan, G. Ramu, and S. M. Rafi, “SAFETY AND TOLERABILITY OF VILDAGLIPTIN IN CLINICAL PRACTICE: NEWER PROMISING GLIPTIN FOR TYPE 2 DIABETES MELLITUS”, IJPBA, vol. 9, no. 1, Mar. 2021.